Fragmin (dalteparin)

DRUG2 trials

Sponsors

Ottawa Hospital Research Institute, Western University, Canada

Conditions

HemodialysisHepatic DiseaseHypercoagulabilitySurgery-ComplicationsThromboembolismThrombosis

Phase 2

A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery

CompletedNCT00260988

Ottawa Hospital Research InstituteHemodialysis, Thromboembolism

Start: 2003-10-31End: 2008-11-30Updated: 2014-09-10

Phase 3

Prolonged Hypercoagulability Following Major Liver Resection for Malignancy

Not yet recruitingNCT06153394

Western University, CanadaHepatic Disease, Hypercoagulability, Surgery-Complications +1

Start: 2024-06-01End: 2028-02-01Target: 50Updated: 2024-04-23